Investigation of the mechanisms governing the release of levamisole from poly-lactide-co-glycolide delivery systems

Journal of Controlled Release

Volumn 42, Issue 2, 1996, Pages 125-132

  Fitzgerald, J F ^a   Corrigan, O I ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Co evaporates; Microspheres; Poly lactide co glycolide; Release mechanisms

Indexed keywords

LEVAMISOLE; MICROSPHERE; POLYGLACTIN; POLYMER;

ARTICLE; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG RELEASE; EVAPORATION; PRIORITY JOURNAL; X RAY DIFFRACTION;

EID: 0030296094     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-3659(96)01450-2     Document Type: Article

References (14)

1. [1] L.R. Beck, D.R. Cowsar, D.H. Lewis, R.J. Cosgrove, C.T. Riddle, S.L. Lowry and T. Epperly, A new long acting injectable microcapsule system for the administration of progesterone. Fertil. Steril. 31(5) (1979) 545-551.
2. [2] H.V. Maulding, T.R. Tice, D.R. Cowsar, J.W. Fong, J.E. Pearson and J.P. Nazareno, Biodegradable microcapsules: Acceleration of polymeric excipient hydrolytic rate by incorporation of a basic medicament. J. Cont. Rel. 3 (1986) 103-117.
3. [3] F.G. Hutchinson and A.B.J. Furr, Biodegradable polymer systems for the sustained release of polypeptides. J. Control. Rel. 13 (1990) 279-294.
4. [4] M. Asano, H. Fukuzaki, M. Yoshida, M. Kumakura, T. Mashimo, H. Yuasa, K. Imai, H. Yamanaka and K. Suzuki, In-vivo characterisation of low molecular weight copoly(l-lactic acid/glycolic acid) formulations with controlled release of luteinizing hormone-releasing hormone agonist. J. Control. Rel. 9 (1989) 111-122.
5. [5] G.E. Visscher, J.E. Pearson, J.W. Fong, J.G. Argientieri, R.L. Robison and H.V.J. Maulding, Effect of particle size on the in-vitro and in vivo degradation rates of poly(DL-lactide-co-glycolide) microcapsules. J. Biomed. Mat. Res. 22 (1988) 733-746.
6. [6] H.V. Maulding, Prolonged delivery of peptides by microcapsules, J. Control. Rel. 6 (1987) 164-176.
7. [7] L.M. Sanders, J.S. Kent, G.I. McRae, B.H. Vickery, T.R. Tice and D.H. Lewis, Controlled release of an LHRH analogue from poly-DL-lactide-co-glycolide microspheres. J. Pharm. Sci. 73 (9) (1984) 1294-1297.
8. [8] J.F. Fitzgerald and O.I. Corrigan, Mechanisms governing drug release from poly-hydroxy aliphatic esters. Diltiazem base release from poly-lactide-co-glycolide delivery systems, in: M.A. El-Nokaly, D.M. Piatt and B.A. Charpentier (Eds.) ACS Symposium Series 520, Polymeric Delivery Systems, Properties and Applications, American Chemical Society, Washington D.C. 1993, pp. 311-326.
9. [9] R. Jalil and J.R. Nixon, Microencapsulation using poly (L-lactic acid) IV: Release properties of microcapsules containing phenobarbitone. J. Microencap. 7 (1990) 53-66.
10. [10] D. Bodmer, T. Kissel and E. Trechslin, Factors influencing the release of peptides and proteins from biodegradable parentral depot systems. J. Control. Rel. 21 (1992) 129-138.
11. [11] V Vidmar, A. Bubalo and I. Jalsenjak, Poly (lactic acid) microencapsulated oxytetracycline: in vitro and in vivo evaluation. J. Microencap. 1 (1984) 131-136.
12. [12] Z. Ramtoola, O.I. Corrigan and C.J. Barrett, Release kinetics of fluphenazine from biodegradable microspheres. J. Microencap. 9 (4) (1992) 415-423.
13. [13] Y. Cha and C.J. Pitt, The acceleration of degradation-controlled drug delivery from polyester microspheres. J. Control. Rel. 8 (1989) 259-265.
14. [14] J.F. Fitzgerald, Z. Ramtoola, C.J. Barrett and O.I. Corrigan, Characterization of polylactide-co-glycolide microspheres containing procaine., Proc. 10th Pharm. Tech, Conf., Bologna, Italy, 1991, 1, 454-465.